表皮生長因子接收器之涎酸醣化對其功能影響之探討

Effect of Sialylation on EGFR Function and Resistance to Tyrosine Kinase Inhibitor Gefitinib

嚴欣勇(Hsin-Yung Yen)

指導教授 ： 翁啟惠

國立臺灣大學/生命科學院/生化科學研究所/博士(2014年)

https://doi.org/10.6342/NTU.2014.02066

摘要

表皮生長因子接收器為一高度醣化且具有酪氨酸磷酸脢活性的膜蛋白，其在細胞中扮演相當重要的角色，包括調節細胞生長、存活、移動以及轉移等能力。表皮生長因子接收器的活化主要受到表皮生長因子刺激，藉由與表皮生長因子結合，表皮生長因子接收器進行蛋白結構之改變而促進其形成二聚體，二聚體之表皮生長因子接收器進而活化其磷酸脢活性並促使接收器本身之酪氨酸磷酸化，最終活化下游訊號傳遞路徑而影響細胞功能。我們先前的研究指出，肺癌細胞中表皮生長因子接受器之涎酸醣化對於其形成二聚體和磷酸化，具有抑制的作用。為了進一步探討涎酸醣化調控表皮生長因子接收器活化的機制，我們利用生物化學的實驗方法，針對表皮生長因子接受器之活化，包含其與表皮生長因子之結合、二聚體化以及磷酸化，進行動力學和質譜學之探討。研究發現，表皮生長因子接收器之涎酸醣化具有抑制接收器與表皮生長因子結合的作用並進而減緩接收器的二聚體化和酪氨酸磷酸化。特別的是，對於具有抗藥性突變之表皮生長因子接收器 （EGFR L858R/T790M），涎酸醣化能特別抑制其酪氨酸1173號位置之磷酸化，並在帶有此突變的肺癌細胞株中，涎酸醣化且具有增進藥物毒殺之效果。此外，肺癌細胞表面之涎酸醣化也具有調節表皮生長因子接受器絲氨酸與蘇氨酸之功能，代表涎酸醣化同時影響表皮生長因子和其它磷酸脢之交互作用。本篇研究深入探討細胞外部之涎酸醣化調節細胞內部表皮生長因子接收器磷酸化之機制，並對於以表皮生長因子接收器為標靶之治療，提供新的方向與契機。

關鍵字

涎酸醣化 ； 表皮生長因子接收器 ； 二聚體化 ； 磷酸化 ； 突變 ； 艾瑞莎

並列摘要

Epidermal growth factor receptor (EGFR) is a heavily glycosylated transmembrane receptor tyrosine kinase. Upon EGF-binding, EGFR commences conformational changes to dimerize, which results in kinase activation and auto-phosphorylation, and the activation of downstream signaling. Previously, we have demonstrated the suppression effect of EGFR sialylation on its dimerization and phosphorylation in lung cancer cells. To further investigate the mechanism of sialylation on EGFR activation and how sialylation regulates EGFR phosphorylation, we investigated the impact of sialylation on the kinetics of EGF-binding and EGFR dimerization as well as autophosphorylation. The result indicated that sialylation of EGFR suppressed EGF/EGFR association, and this negative regulatory effect was confirmed by downregulation of tyrosine phosphosites in EGFR. Moreover, sialylation showed significant impact on EGFR serine/threonine phosphorylation in lung cancer cells and affected the interactive dynamics between EGFR and other kinases. Of particular interest is a site-specific suppression of pY1173 by sialylation was observed in an EGFR tyrosine kinase inhibitor (TKI)-resistant mutant (L858R/T790M) and the sensitivity to gefitinib was enhanced by sialylation in the lung cancer cell line with this EGFR mutant. Our studies showed a selective effect on the phosphorylation of a TKI-resistant mutant, and this observation may provide insights into a new therapeutic intervention.

並列關鍵字

EGFR ； sialylation ； dimerization ； phosphorylation ； mutation ； gefitinib

參考文獻

1. Mitsudomi T & Yatabe Y (2010) Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. The FEBS journal 277(2):301-308.

2. Miettinen PJ, et al. (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376(6538):337-341.

3. Threadgill DW, et al. (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269(5221):230-234.

4. Sibilia M & Wagner EF (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269(5221):234-238.

5. Sibilia M, Steinbach JP, Stingl L, Aguzzi A, & Wagner EF (1998) A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. The EMBO journal 17(3):719-731.